How long does adalimumab injection take to stop the drug according to the patient’s specific type of disease, condition, personal situation and other factors are different and there is a big difference, can not be generalized, and some patients with some diseases may need long-term maintenance treatment. Adalimumab is a fully humanized tumor necrosis factor α monoclonal antibody, is currently mainly used in the treatment of rheumatoid arthritis, psoriasis, ankylosing spondylitis and Crohn’s disease, etc. According to the specific type of disease, condition, personal situation and other factors are different, the specific use of the drug dosage and length of treatment there are greater differences. For example, for the treatment of rheumatoid arthritis, 40mg is injected subcutaneously every two weeks, and the immune response can be obtained in about 12 weeks, that is, the drug may be discontinued in 12 weeks. While for the treatment of psoriasis, ankylosing spondylitis and Crohn’s disease and other diseases, may be adalimumab to play more than 12 weeks to stop. Patients who are allergic to the components of the drug adalimumab, patients with active tuberculosis and patients with moderate-to-severe heart failure and other patients with contraindications to the drug adalimumab are prohibited from using the drug treatment. Precautions: there has been no report of secondary infection transmission caused by live vaccines in patients treated with this product, in addition to live vaccines, patients using this product can receive vaccination at the same time. Adalimumab how long to stop playing need to be evaluated under the guidance of a physician, it is recommended that patients who need to use adalimumab treatment to the rheumatology and immunology department of regular hospitals and other related departments for consultation.